Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Invesco NASDAQ 100 ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.59 (market cap $4.59B), while Invesco NASDAQ 100 ETF trades at $310 (market cap $113.40B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 24.7× Definium Therapeutics Inc. Common Shares's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Invesco NASDAQ 100 ETF for 54 Days on average.
| DFTX | QQQM | |
|---|---|---|
Market Cap | $4.59B | $113.40B |
Volume | 2,103,937 | 2,866,236 |
Sector | Health | Broad Market / Factor |
52-Week High | $48.45 | $312.76 |
52-Week Low | $10.68 | $229.87 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM trades at $312.01, down 0.24% on the day, with a bullish technical outlook supported by moving averages but showing overbought conditions on shorter-term RSI readings. The ETF maintains its focus on Nasdaq-100 exposure with a competitive 0.15% expense ratio. Recent institutional activity shows increased interest, with QRG Capital Management boosting its position by 207.5% in Q2 2026.
The ETF's outlook remains positive given Nasdaq-100 leadership, though investors should monitor valuation levels and potential market rotation. Key risks include technology sector concentration and market volatility, while the lower fee structure provides a structural advantage for long-term holders seeking Nasdaq-100 exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
